Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Options to Purchase Common Stock [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities	40	74
Restricted stock units (RSUs) [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities		1
Pre-2024 warrants for common stock [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities	660	664
Class A warrants for common stock [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities	310	310
Class B warrants for common stock [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities	9	9
January 2024 warrants for common stock [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities	6,730	6,730
January 2024 placement agent warrants for common stock [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities	471	471
Class C warrants for common stock [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities	287,491	1,372,586
Class D warrants for common stock [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities		197,467
Class E warrants for common stock [Member]
Schedule of Potentially Dilutive Securities Not Included in the Calculation of Diluted Net Loss Per Share [Line Items]
Potentially dilutive securities	1,085,106

Bluejay Diagnostics, Inc. 10-Q